Sydney, Australia - Beroni Group an Australia-based diversified biopharmaceutical enterprise today announced that it has signed a Memorandum of Understanding with tella, Inc. to collaborate in the field of immunotherapy for cancer treatment. tella is a Japanese company contributing to the advancement of cancer therapy through the research and development of cancer vaccines. tella's dendritic cell vaccine therapy .
Beroni Group (OTCMKTS:BNIGF) (NSX:BTG), an Australia-based diversified biopharmaceutical enterprise today announced that it has signed a Memorandum of Understanding with tella, Inc. to collaborate in the field of immunotherapy for cancer treatment.